Clinical Trial Update: UARK 2008-02 A Trial for High-risk Myeloma Evaluating Accelerating and Sustaining Complete Remission [Phase 2]

View source ↗

Summary

Phase 2 trial by the University of Arkansas for high-risk multiple myeloma evaluating accelerating and sustaining complete remission is currently active but not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: University of Arkansas | Conditions: Multiple Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING